Morphea - I-Morphea
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Isilonda sika-I-Morphea (Morphea) ngokuvamile sivela njengesichibi esinemibala e-atrophic.
References
I- Scleroderma yisifo esingavamile esithinta izicubu ezixhumeneyo, ezibonakala njengesikhumba esiqinile futhi kwesinye isikhathi sithinte ezinye izingxenye zomzimba. Kunezinhlobo ezimbili eziyinhloko: systemic sclerosis , ezibandakanya ukuqina kwesikhumba nezitho zangaphakathi, kanye ne- localized scleroderma , eyaziwa nangokuthi i-morphea, ehlala ikhawulelwe esikhumbeni naseziculweni ezingaphansi kwayo, enenkambo elungile futhi yokuzikhawulela. Nakuba i-localized scleroderma ingavamile futhi imbangela yaso ingacacile, ucwaningo lwakamuva lubonisa ukuthi ingathinta nezitho zangaphakathi futhi iholele ezinkingeni ezihlukahlukene zezempilo. Ukwelashwa kusenesikhathi kubalulekile ukuze kuvinjelwe izinkinga, uma kubhekwa ubucayi obungaba khona be- localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , eyaziwa nangokuthi i-localized scleroderma, yisifo esingajwayelekile sokuzivikela komzimba esithinta izicubu ezixhumeneyo. Ingavela ngezindlela ezihlukene, futhi ayijwayelekile kakhulu, cishe ngamakesi angu- 0. 4 - 2. 7 kubantu abangu-100,000 unyaka ngamunye. I- Morphea ivame ukubonakala ezinganeni ezineminyaka engu-2 kuya kwengu-14 ubudala, futhi ijwayele ukuphatha amantombazane kaningi kunabafana.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
I-Morphea yisifo esingavamile kakhulu. Ngenxa yokwakheka kwesithombe, i-algorithm kungenzeka iyenze iphutha ngokuthi i-morphea (morphea) .